Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
Viruses · 2023
DOI: 10.3390/v15030677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Olga Tronina und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Direct-acting antivirals (DAA) regimens have provided hope for eliminating hepatitis C virus (HCV) infection. Patients following ineffective therapy with DAA, especially those previously treated with inhibitors of non-structural protein 5A (NS5A), remain a challenge. The study aimed to assess the effectiveness of DAA pangenotypic options in patients after failure of NS5A containing genotype-specific regimens. The analysis included 120 patients selected from the EpiTer-2 database with data on 15675 HCV-infected individuals treated with IFN-free therapies from 1 July 2015 to 30 June 2022 at 22 Polish hepatology centres. The majority of them were infected with genotype (GT) 1b (85.8%) and one-third was diagnosed with fibrosis F4. Among the rescue pangenotypic regimens, the most commonly used was the sofosbuvir/velpatasvir (SOF/VEL) ± ribavirin (RBV) combination. The sustained virologic response, which was a measure of treatment effectiveness, was achieved by 102 patients, resulting in cure rate of 90.3% in the per protocol analysis. All 11 non-responders were infected with GT1b, 7 were diagnosed with cirrhosis, and 9 were treated with SOF/VEL±RBV. We demonstrated the high effectiveness of the pangenotypic rescue options in patients after genotype specific NS5A-containing regimens failures, identifying cirrhosis as a negative prognostic factor of treatment effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland.
- Department of Infectious Diseases, Voivodship Hospital, 25-317 Kielce, Poland.
- Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland.
- Pomeranian Center of Infectious Diseases, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
- Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, 40-055 Katowice, Poland.
ORCID-Profile: Michał Brzdęk, Dorota Zarębska-Michaluk, Dorota Dybowska, Beata Lorenc, Ewa Janczewska, Anna Piekarska, Rafał Krygier, Jakub Klapaczyński, Robert Flisiak
Zitieren
APA
Tronina, O., Brzdęk, M., Zarębska-Michaluk, D., Dybowska, D., Lorenc, B., Janczewska, E., Mazur, W., Parfieniuk-Kowerda, A., Piekarska, A., Krygier, R., Klapaczyński, J., Berak, H., Jaroszewicz, J., Garlicki, A., Tomasiewicz, K., Citko, J., & Flisiak, R. (2023). Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens. Viruses. https://doi.org/10.3390/v15030677
Vancouver
Tronina O, Brzdęk M, Zarębska-Michaluk D, Dybowska D, Lorenc B, Janczewska E, et al. Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens. Viruses. 2023. doi:10.3390/v15030677
BibTeX
@article{Tronina2023,
author = {Tronina, Olga and Brzdęk, Michał and Zarębska-Michaluk, Dorota and Dybowska, Dorota and Lorenc, Beata and Janczewska, Ewa and Mazur, Włodzimierz and Parfieniuk-Kowerda, Anna and Piekarska, Anna and Krygier, Rafał and Klapaczyński, Jakub and Berak, Hanna and Jaroszewicz, Jerzy and Garlicki, Aleksander and Tomasiewicz, Krzysztof and Citko, Jolanta and Flisiak, Robert},
title = {Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030677}
}
EUVIMED